Lots of speculation that COV may try and acquire ROCM. May hurt BCR's business?
ROCM is now cheap after the stock has crashed and COV faces a significant legal liability against ROCM.
ROCM antibacterial catheter is patent protected and demonstrated superior in the space. Medicare will no longer reimburse for infections and ROCM product dramatically reduces infections, state govt measuring infection rates, and an aging population. Does seem to make sensse.